{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:45:45Z","timestamp":1767847545967,"version":"3.49.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006484","name":"Vifor Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ejps.2019.105180","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T02:24:04Z","timestamp":1575944644000},"page":"105180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Iron polymaltose complexes: Could we spot physicochemical differences in medicines sharing the same active pharmaceutical ingredient?"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0029-1683","authenticated-orcid":false,"given":"Tiziana","family":"Di Francesco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e9adie","family":"Delafontaine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Philipp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elmira","family":"Lechat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6268-2586","authenticated-orcid":false,"given":"Gerrit","family":"Borchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2019.105180_bib0001","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/S0140-6736(19)30041-8","article-title":"Health effects of dietary risks in 195 countries, 1990 -2017: a systematic analysis for the Global Burden of Disease Study","volume":"393","author":"Afshin","year":"2019","journal-title":"Lancet North Am. Ed."},{"key":"10.1016\/j.ejps.2019.105180_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135967","article-title":"Efficiency of original versus generic intravenous iron formulations in patients on haemodialysis","volume":"10","author":"Ag\u00fcera","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2019.105180_bib0003","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.amjmed.2008.07.012","article-title":"Individualized treatment for iron-deficiency anemia in adults","volume":"121","author":"Alleyne","year":"2008","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejps.2019.105180_bib0004","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4103\/1110-1067.186392","article-title":"Effects of oral iron (ferrous versus ferric) supplementation on oxidative stress and antioxidant status in pregnant women with iron deficiency: controlled trial","volume":"41","author":"Aly","year":"2016","journal-title":"Egypt. J. Haematol."},{"issue":"Suppl 1","key":"10.1016\/j.ejps.2019.105180_bib0005","doi-asserted-by":"crossref","first-page":"E326","DOI":"10.1055\/s-2007-966820","article-title":"Iron-induced esophageal ulceration","volume":"39","author":"Areia","year":"2007","journal-title":"Endoscopy"},{"key":"10.1016\/j.ejps.2019.105180_bib0006","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.yrtph.2012.08.009","article-title":"Nanoparticle iron medicinal products - Requirements for approval of intended copies of non-biological complex drugs (NBCD) and the importance of clinical comparative studies","volume":"64","author":"Borchard","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.ejps.2019.105180_bib0007","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.bbagen.2011.07.014","article-title":"Non-transferrin bound iron: a key role in iron overload and iron toxicity","volume":"1820","author":"Brissot","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejps.2019.105180_bib0008","first-page":"360","article-title":"Interactions between iron(III)-hydroxide polymaltose complex and commonly used drugs \/ simulations and in vitro studies","volume":"57","author":"Burckhardt-Herold","year":"2007","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejps.2019.105180_bib0009","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1056\/NEJMra1401038","article-title":"Iron-Deficiency Anemia","volume":"372","author":"Camaschella","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2019.105180_bib0010","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2125.1991.tb05525.x","article-title":"Iron supplements: a common cause of drug interactions","volume":"31","author":"Campbell","year":"1991","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2019.105180_bib0011","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00000441-199910000-00002","article-title":"Iron Absorption and Transport","volume":"318","author":"Conrad","year":"1999","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.ejps.2019.105180_bib0012","series-title":"Non-Biological Complex Drugs: The Science and the Regulatory Landscape","first-page":"1","article-title":"Introduction: defining the position of non-biological complex drugs","author":"Crommelin","year":"2015"},{"key":"10.1016\/j.ejps.2019.105180_bib0013","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1208\/s12248-019-0329-7","article-title":"Report of the AAPS guidance forum on the FDA Draft Guidance for Industry: \u201cdrug products, including biological products, that contain nanomaterials","volume":"21","author":"de Vlieger","year":"2019","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2019.105180_bib0014","first-page":"303","article-title":"Effects of oral iron(III) hydroxide polymaltose complex supplementation on hemoglobin increase, cognitive function, affective behavior and scholastic performance of adolescents with varying iron status: a single centre prospective placebo controlled study","volume":"59","author":"Devaki","year":"2009","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejps.2019.105180_bib0015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/nyas.13517","article-title":"Iron sucrose: assessing the similarity between the originator drug and its intended copies","volume":"1407","author":"Di Francesco","year":"2017","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.ejps.2019.105180_bib0016","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10534-007-9116-5","article-title":"Non-transferrin-bound iron in plasma following administration of oral iron drugs","volume":"21","author":"Dresow","year":"2008","journal-title":"Biometals"},{"key":"10.1016\/j.ejps.2019.105180_bib0017","first-page":"370","article-title":"Interactions between iron(III)-hydroxide polymaltose complex and commonly used medications \/ laboratory studies in rats","volume":"57","author":"Funk","year":"2007","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejps.2019.105180_bib0018","first-page":"439","article-title":"Safety and efficacy of iron(III)-hydroxide polymaltose complex - a review of over 25 years experience","volume":"57","author":"Geisser","year":"2007","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejps.2019.105180_bib0019","first-page":"1439","article-title":"Structure\/histotoxicity relationship of parenteral iron preparations","volume":"42","author":"Geisser","year":"1992","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejps.2019.105180_bib0020","doi-asserted-by":"crossref","first-page":"604","DOI":"10.12669\/pjms.323.9799","article-title":"Medication adherence to oral iron therapy in patients with iron deficiency anemia","volume":"32","author":"Gereklioglu","year":"2016","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.ejps.2019.105180_bib0022","unstructured":"Helenek, M.J., et\u00a0al., (2005). Patent US 7169359 B2: Bioequivalence test for iron-containing formulations, in: Inc, L.P. (Ed.). Luitpold Pharmaceuticals Inc."},{"key":"10.1016\/j.ejps.2019.105180_bib0021","article-title":"Measuring the size of nanoparticles in aqueous media using batch-mode dynamic light scattering.","author":"Hackley","year":"2015","journal-title":"NIST-NCL Special Publication 1200-6"},{"key":"10.1016\/j.ejps.2019.105180_bib0023","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/nyas.13347","article-title":"Equivalence of complex drug products: advances in and challenges for current regulatory frameworks","volume":"1407","author":"Hussaarts","year":"2017","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejps.2019.105180_bib0024","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/10245332.2000.11746490","article-title":"Better tolerance of iron polymaltose complex compared with ferrous sulphate in the treatment of anaemia","volume":"5","author":"Jacobs","year":"2000","journal-title":"Hematology"},{"key":"10.1016\/j.ejps.2019.105180_bib0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.14227\/DT160309P21","article-title":"Biorelevant dissolution media simulating the proximal human gastrointestinal tract: an update","volume":"16","author":"Jantraid","year":"2009","journal-title":"Dissol. Technol."},{"key":"10.1016\/j.ejps.2019.105180_bib0026","doi-asserted-by":"crossref","first-page":"9","DOI":"10.9790\/0853-0910913","article-title":"Comparative study of efficacy and safety of Iron polymaltose complex with ferrous sulphate in antenatal women with moderate anemia","volume":"9","author":"Kambar","year":"2013","journal-title":"IOSR J. Dental. Medi. Sci. (IOSR-JDMS"},{"key":"10.1016\/j.ejps.2019.105180_bib0027","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejps.2019.03.029","article-title":"The EU regulatory landscape of non-biological complex drugs (NBCDs) follow-on products: Observations and recommendations","volume":"133","author":"Klein","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2019.105180_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11051-013-1902-0","article-title":"Magnetic properties of ferritin and akaganeite nanoparticles in aqueous suspension","volume":"15","author":"Koralewski","year":"2013","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.ejps.2019.105180_bib0029","first-page":"191","article-title":"Treatment of iron-deficiency anaemia: A lower incidence of adverse effects with Ferrum Hausmann than ferrous sulphate","volume":"4","author":"Langstaff","year":"1993","journal-title":"Br. J. Clin. Res."},{"key":"10.1016\/j.ejps.2019.105180_bib0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1185\/03007995.2012.760444","article-title":"Comparison of adverse event profile of intravenous iron sucrose and iron sucrose similar in postpartum and gynecologic operative patients","volume":"29","author":"Lee","year":"2013","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.ejps.2019.105180_bib0031","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0140-6736(15)60865-0","article-title":"Iron deficiency anaemia","volume":"387","author":"Lopez","year":"2016","journal-title":"Lancet North Am. Ed."},{"key":"10.1016\/j.ejps.2019.105180_bib0032","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/ajcn\/10.2.124","article-title":"Effect of Sorbitol on Iron Absorption in Man","volume":"10","author":"Loria","year":"1962","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ejps.2019.105180_bib0033","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1358\/mf.2004.26.6.831316","article-title":"Kinetics of two different iron formulations and their effect on diurnal variation of serum iron levels","volume":"26","author":"Malhotra","year":"2004","journal-title":"Methods Find Exp. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2019.105180_bib0034","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1093\/ndt\/gfr711","article-title":"Effects of intravenous iron on mononuclear cells during the haemodialysis session","volume":"27","author":"Martin-Malo","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejps.2019.105180_bib0035","first-page":"279","article-title":"Iron hydroxide polymaltose: iatrogenic cause of persistent iron deficiency anaemia despite continuous oral iron therapy","volume":"50","author":"Mehta","year":"2002","journal-title":"J. Assoc. Physicians India"},{"key":"10.1016\/j.ejps.2019.105180_bib0036","first-page":"419","article-title":"Ineffectiveness of iron polymaltose in treatment of iron deficiency anemia","volume":"51","author":"Mehta","year":"2003","journal-title":"J. Assoc. Physicians India"},{"key":"10.1016\/j.ejps.2019.105180_bib0037","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ensci.2018.05.006","article-title":"Physicochemical, biological, functional and toxicological characterization of the European follow-on glatiramer acetate product as compared with Copaxone","volume":"12","author":"Melamed-Gal","year":"2018","journal-title":"eNeurologicalSci"},{"key":"10.1016\/j.ejps.2019.105180_bib0038","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.addr.2018.06.024","article-title":"Regulatory challenges of nanomedicines and their follow-on versions: A generic or similar approach?","volume":"131","author":"M\u00fchlebach","year":"2018","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ejps.2019.105180_bib0039","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.2147\/IJN.S129300","article-title":"Protein corona: a new approach for nanomedicine design","volume":"12","author":"Nguyen","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejps.2019.105180_bib0040","first-page":"743","article-title":"Bioavailability of iron from oral ferric polymaltose in humans","volume":"44","author":"Nielsen","year":"1994","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejps.2019.105180_bib0041","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3109\/14767058.2011.599080","article-title":"Efficacy and safety of oral iron(III) polymaltose complex versus ferrous sulfate in pregnant women with iron-deficiency anemia: a multicenter, randomized, controlled study","volume":"24","author":"Ortiz","year":"2011","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.ejps.2019.105180_bib0042","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.nano.2014.06.012","article-title":"Nanoparticulate iron(III) oxo-hydroxide delivers safe iron that is well absorbed and utilised in humans","volume":"10","author":"Pereira","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejps.2019.105180_bib0043","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1001\/jama.2017.6846","article-title":"Effect of low-dose ferrous sulfate vs iron polysaccharide complex on hemoglobin concentration in young children with nutritional iron-deficiency anemia: A randomized clinical trial","volume":"317","author":"Powers","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ejps.2019.105180_bib0045","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1093\/ndt\/gfr024","article-title":"Do two intravenous iron sucrose preparations have the same efficacy","volume":"26","author":"Rottembourg","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejps.2019.105180_bib0044","article-title":"The complete study of the switch from iron-sucrose originator to iron sucrose similar and vice versa in hemodialysis patients","volume":"2","author":"Rottembourg","year":"2016","journal-title":"J. Kidney"},{"key":"10.1016\/j.ejps.2019.105180_bib0046","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/10245330701214160","article-title":"Ineffectiveness of oral iron hydroxide polymaltose in iron-deficiency anemia","volume":"12","author":"Ruiz-Arg\u00fcelles","year":"2007","journal-title":"Hematology"},{"key":"10.1016\/j.ejps.2019.105180_bib0047","first-page":"1","article-title":"Comparison of efficacy, tolerability, and cost of iron polymaltose complex with ferrous sulphate in the treatment of iron deficiency anemia in pregnant women","volume":"9","author":"Saha","year":"2007","journal-title":"Medscape Gen. Med."},{"key":"10.1016\/j.ejps.2019.105180_bib0048","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1100\/2012\/846824","article-title":"Ferrous versus ferric oral iron formulations for the treatment of iron deficiency: a clinical overview","volume":"2012","author":"Santiago","year":"2012","journal-title":"Scient. World J."},{"key":"10.1016\/j.ejps.2019.105180_bib0049","first-page":"1575","article-title":"On the therapeutic effects of trivalent and divalent iron in iron deficiency anaemia","volume":"34","author":"Sas","year":"1984","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejps.2019.105180_bib0050","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.yrtph.2010.09.021","article-title":"The therapeutic equivalence of complex drugs","volume":"59","author":"Schellekens","year":"2011","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.ejps.2019.105180_bib0051","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/156482651303400207","article-title":"Differences in Circulating Non-Transferrin-Bound Iron after Oral Administration of Ferrous Sulfate, Sodium Iron EDTA, or Iron Polymaltose in Women with Marginal Iron Stores","volume":"34","author":"Sch\u00fcmann","year":"2013","journal-title":"Food Nutr. Bull."},{"key":"10.1016\/j.ejps.2019.105180_bib0052","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/156482651203300206","article-title":"Oral Administration of Ferrous Sulfate, but not of Iron Polymaltose or Sodium Iron Ethylenediaminetetraacetic Acid (NaFeEDTA), Results in a Substantial Increase of Non-Transferrin-Bound Iron in Healthy Iron-Adequate Men","volume":"33","author":"Sch\u00fcmann","year":"2012","journal-title":"Food Nutr. Bull."},{"key":"10.1016\/j.ejps.2019.105180_bib0053","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2018.00360","article-title":"Nanomedicine: Principles, Properties, and Regulatory Issues","volume":"6","author":"Soares","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejps.2019.105180_bib0054","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1185\/03007995.2011.651527","article-title":"Clinical case reports raise doubts about the therapeutic equivalence of an iron sucrose similar preparation compared with iron sucrose originator","volume":"28","author":"Stein","year":"2012","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.ejps.2019.105180_bib0055","series-title":"Findings from the Global Burden of Disease Study 2017","year":"2018"},{"key":"10.1016\/j.ejps.2019.105180_bib0056","series-title":"Iron Deficiency Anaemia: Assessment, Prevention and Control - A Guide for Programme Managers","year":"2001"},{"key":"10.1016\/j.ejps.2019.105180_bib0057","series-title":"Worlwide Prevalence of Anaemia 1993-2005","year":"2008"},{"key":"10.1016\/j.ejps.2019.105180_bib0058","series-title":"WHO Model Lists of Essential Medicines 20th Edition","year":"2017"},{"key":"10.1016\/j.ejps.2019.105180_bib0059","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10534-015-9822-3","article-title":"Nitrosative stress and apoptosis in non-anemic healthy rats induced by intravenous iron sucrose similars versus iron sucrose originator","volume":"28","author":"Toblli","year":"2015","journal-title":"Biometals"},{"key":"10.1016\/j.ejps.2019.105180_bib0060","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.placenta.2011.11.017","article-title":"Effects of iron deficiency anemia and its treatment with iron polymaltose complex in pregnant rats, their fetuses and placentas: oxidative stress markers and pregnancy outcome","volume":"33","author":"Toblli","year":"2012","journal-title":"Placenta"},{"key":"10.1016\/j.ejps.2019.105180_bib0061","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000142728","article-title":"Comparative study of gastrointestinal tract and liver toxicity of ferrous sulfate, iron amino chelate and iron polymaltose complex in normal rats","volume":"82","author":"Toblli","year":"2008","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejps.2019.105180_bib0062","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117383","article-title":"Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis","volume":"10","author":"Tolkien","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2019.105180_bib0063","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0271-5317(99)00073-1","article-title":"Oral supplementation with ferrous sulfate but not with non-ionic iron polymaltose complex increases the susceptibility of plasma lipoproteins to oxidation","volume":"19","author":"Tuomainen","year":"1999","journal-title":"Nutr. Res."},{"key":"10.1016\/j.ejps.2019.105180_bib0064","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/wnan.1338","article-title":"Product quality for nanomaterials: current U.S. experience and perspective","volume":"7","author":"Tyner","year":"2015","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.ejps.2019.105180_bib0065","unstructured":"United States Pharmacopeial Convention, (2017). USP 40-NF35 S 1 - Good storage and distribution practices for drug products, in: 1, U.-N.S. (Ed.). USP."},{"key":"10.1016\/j.ejps.2019.105180_bib0066","series-title":"MaltoferP-Product monograph, Swiss Iron ed.","year":"2017"},{"key":"10.1016\/j.ejps.2019.105180_bib0067","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/524520","article-title":"Efficacy, tolerability, and acceptability of iron hydroxide polymaltose complex versus ferrous sulfate: a randomized trial in pediatric patients with iron deficiency anemia","volume":"2011","author":"Yasa","year":"2011","journal-title":"Int. J. Pediatr."},{"key":"10.1016\/j.ejps.2019.105180_bib0068","first-page":"506","article-title":"Iron polymaltose complex in the treatment of iron deficiency anemia in pregnancy","volume":"25","author":"Yasmeen","year":"2016","journal-title":"Mymensingh Med. J."},{"key":"10.1016\/j.ejps.2019.105180_bib0069","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1208\/s12248-017-0044-1","article-title":"Scientific and regulatory considerations for generic complex drug products containing nanomaterials","volume":"19","author":"Zheng","year":"2017","journal-title":"Aaps J."},{"key":"10.1016\/j.ejps.2019.105180_bib0070","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1208\/s12248-017-0126-0","article-title":"Physicochemical Characterization of Iron Carbohydrate Colloid Drug Products","volume":"19","author":"Zou","year":"2017","journal-title":"The AAPS Journal"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098719304531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098719304531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:51:52Z","timestamp":1760529112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098719304531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":70,"alternative-id":["S0928098719304531"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2019.105180","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iron polymaltose complexes: Could we spot physicochemical differences in medicines sharing the same active pharmaceutical ingredient?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2019.105180","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105180"}}